HER-2/neu vaccine

Phase I trial of novel HER2/neu Antigens will Start at Mayo; Isis Initiates Phase 2 Study of ISIS-APOCIIIRx
BioMedReports
Sat, 05/5/12 - 04:31 pm
TapImmune
HER-2/neu vaccine
vaccines
Isis Pharmaceuticals
ISIS-APOCIIIRx
hypertriglyceridemia